The significance of its role in niche regulation is highlighted by the fact that AREG expression on CML sEVs is correlated to aggressiveness and chemoresistance in patients [103]. The gene discussed is AREG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.